On January 22, IFBH (06603) spent approximately HKD 2.653 million to repurchase 145,000 shares.
IFBH (06603) announced on January 22, 2026, to spend approximately 2.6553 million Hong Kong dollars to repurchase 145,000 shares.
IFBH (06603) announced on January 22, 2026, that it will spend approximately 2.6553 million Hong Kong dollars to repurchase 145,000 shares.
Related Articles
LINGBAO GOLD (03330): Huang Hui appointed as independent non-executive director.
LEADS BIOLABS-B(09887): Vitrakvi has been granted orphan drug designation (ODD) by the European Commission for the treatment of pulmonary neuroendocrine tumors.
MACAU LEGEND (01680) raised approximately HK$86.4 million from the issuance of new shares.
LINGBAO GOLD (03330): Huang Hui appointed as independent non-executive director.
LEADS BIOLABS-B(09887): Vitrakvi has been granted orphan drug designation (ODD) by the European Commission for the treatment of pulmonary neuroendocrine tumors.
MACAU LEGEND (01680) raised approximately HK$86.4 million from the issuance of new shares.
RECOMMEND
Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026
Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026
Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026
